Oxytocin and cholecystokinin secretion in women with colectomy.
BACKGROUND
Cholecystokinin (CCK) concentrations in plasma have been shown to be significantly higher in colectomised subjects compared to healthy controls. This has been ascribed to reduced inhibition of CCK release from colon. In an earlier study CCK in all but one woman who was colectomised, induced release of oxytocin, a peptide present throughout the gastrointestinal (GI) tract. The aim of this study was thus to examine if colectomised women had a different oxytocin response to CCK compared to healthy controls.


METHODS
Eleven women, mean age 34.4 +/- 2.3 years, who had undergone colectomy because of ulcerative colitis or constipation were studied. Eleven age-matched healthy women served as controls. All subjects were fasted overnight and given 0.2 microg/kg body weight of CCK-8 i.v. in the morning. Samples were taken ten minutes and immediately before the injection, and 10, 20, 30, 45, 60, 90 and 120 min afterwards. Plasma was collected for measurement of CCK and oxytocin concentrations.


RESULTS
The basal oxytocin and CCK concentrations in plasma were similar in the two groups. Intravenous injection of CCK increased the release of oxytocin from 1.31 +/- 0.12 and 1.64 +/- 0.19 pmol/l to 2.82 +/- 0.35 and 3.26 +/- 0.50 pmol/l in controls and colectomised women, respectively (p < 0.001). Given the short half-life of CCK-8 in plasma, the increased concentration following injection could not be demonstrated in the controls. On the other hand, in colectomised women, an increase of CCK in plasma was observed for up to 20 minutes after the injection, concentrations increasing from 1.00 +/- 0.21 to a maximum of 1.81 +/- 0.26 pmol/l (p < 0.002).


CONCLUSIONS
CCK stimulates the release of oxytocin in women. There is no difference in plasma concentrations between colectomised and controls. However, colectomy seems to reduce the metabolic clearance of CCK. The hyperCCKemia in patients who had undergone colectomy is consequently not only dependent on CCK release, but may also depend on reduced clearance.
Department of Medicine, University Hospital, S-205 02 Malmö, Sweden. bodil.ohlsson@kir.lu.se
Bodil
B
Ohlsson
Jens F
JF
Rehfeld
Mary L
ML
Forsling
D000328:Adult; D016022:Case-Control Studies; D002766:Cholecystokinin / Q000008:administration & dosage / Q000097:blood*; D003082:Colectomy; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D010121:Oxytocin / Q000097:blood / Q000378:metabolism*; D010446:Peptide Fragments / Q000008:administration & dosage
D010446:Peptide Fragments; C410885:cholecystokinin 8; D010121:Oxytocin; D002766:Cholecystokinin